Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease
Mounjaro is often prescribed off-label for weight management, but only for patients who meet the necessary criteria, making this thorough evaluation an important part of the process
PlexusDx specializes in direct-to-patient access, requiring no insurance, membership, or prior authorization
But what dramatic headlines dont tell you is that the actual risk is low, and theres a ton of context missing
The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease
(PubMed) Huang C, Hu J, Subedi KP, et al